000			01809nam a2200349 a 4500
001			ebr10425162
003			CaPaEBR
007			cr cn|||||||||
008			101202s2010 dcua sb 100 0 eng d
020			_z9780309158497
020			_z0309158494
040			_aCaPaEBR _cCaPaEBR
035			_a(OCoLC)690162710
043			_an-us---
050	1	4	_aRA399.A3 _bI57 2010eb
110	2		_aInstitute of Medicine (U.S.). _bCommittee on the Public Health Effectiveness of the FDA 510(k) Clearance Process.
245	1	0	_aPublic health effectiveness of the FDA 510(k) clearance process _h[electronic resource] : _bbalancing patient safety and innovation : workshop report / _cTheresa Wizemann, editor ; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.
246	3	0	_aFDA 510(k) clearance process
260			_aWashington, D.C. : _bNational Academies Press, _c2010.
300			_axii, 128 p. : _bcol. ill.
504			_aIncludes bibliographical references.
533			_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2010. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries.
610	1	0	_aUnited States. _bFood and Drug Administration.
650		0	_aPublic health _xStandards _zUnited States _vCongresses.
650		0	_aPublic health _zUnited States _vCongresses.
655		7	_aElectronic books. _2local
700	1		_aWizemann, Theresa.
710	2		_aInstitute of Medicine (U.S.). _bBoard on Population Health and Public Health Practice.
710	2		_aebrary, Inc.
856	4	0	_uhttp://site.ebrary.com/lib/kliuc/Doc?id=10425162 _zAn electronic book accessible through the World Wide Web; click to view
999			_c78642 _d78642